AmbioPharm, Inc.

1024 Dittman Court
SC 29842 North Augusta
US

Contact WebSite

AmbioPharm was founded in 2006 and is one of the largest peptide commercial manufacturers in the world. With facilities in North Augusta (South Carolina) and Shanghai, the organization employs more than 500 chemists and industry professionals. AmbioPharm has developed a unique business model designed to handle all types of peptide manufacturing.

Article

15.11.2024 • News

Ambiopharm Breaks Ground on $28 Million Expansion

Ambiopharm, a US-based pharmaceutical services company specializing in peptide manufacturing, recently announced the groundbreaking of a 70,000-square-foot (6,504 m2) capacity expansion project at its Shanghai manufacturing site. This $28 million (€26.6 million) project reflects the company’s commitment to serving growing global demand and confidence in China’s vital role in the global pharmaceutical supply chain.

04.10.2023 • News

AmbioPharm Appoints Brian Gregg as CEO

Contract development and manufacturing organization (CDMO) AmbioPharm has appointed industry veteran Brian Gregg as CEO. Gregg, who has more than 30 years of experience in the peptide CDMO industry, succeeds Tim Nieters, who will be stepping down after seven years with the company.